| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 检测设备及试剂(元) | 87,842,819.14 | 29,953,432.41 | 121,154,941.13 | 50,273,107.66 |
| 血液制品生产及销售(元) | 7,251,907,447.46 | 3,921,145,334.48 | 8,052,459,365.49 | 4,201,108,790.87 |
| 营业成本(元) | ||||
| 检测设备及试剂(元) | 66,076,002.60 | 19,572,873.43 | 78,125,197.87 | 30,007,561.55 |
| 血液制品生产及销售(元) | 4,534,874,270.30 | 2,441,186,711.06 | 4,778,738,026.01 | 2,483,868,633.80 |
| 毛利(元) | ||||
| 检测设备及试剂(元) | 21,766,816.54 | 10,380,558.98 | 43,029,743.26 | 20,265,546.11 |
| 血液制品生产及销售(元) | 2,717,033,177.16 | 1,479,958,623.42 | 3,273,721,339.48 | 1,717,240,157.07 |
| 毛利率(%) | ||||
| 检测设备及试剂(%) | 24.78 | 34.66 | 35.52 | 40.31 |
| 血液制品生产及销售(%) | 37.47 | 37.74 | 40.65 | 40.88 |
| 收入构成(%) | ||||
| 检测设备及试剂(%) | 1.20 | 0.76 | 1.48 | 1.18 |
| 血液制品生产及销售(%) | 98.80 | 99.24 | 98.52 | 98.82 |
| 毛利构成(%) | ||||
| 检测设备及试剂(%) | 0.79 | 0.70 | 1.30 | 1.17 |
| 血液制品生产及销售(%) | 99.21 | 99.30 | 98.70 | 98.83 |